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TIP30 (Tat-interacting protein 30), a newly found proapoptotic factor, appears to be involved in multiple functions including metabolic
suppression, apoptosis induction, and diminishing angiogenic properties. In the present study, we reported that mitochondrial events were required
for apoptosis induced by TIP30 in hepatocellular carcinoma cells (HCC cells). Translocation of Bax was essential for TIP30-induced apoptosis,
whereas overexpression of the anti-apoptotic protein Bcl-xL delayed both second mitochondria-derived activator of caspases (Smac/DIABLO)
release and onset of apoptosis. Furthermore, TIP30-induced apoptosis was dependent on caspase activity because the pan-caspase inhibitor
benzyloxycarbonyl-Val-Ala-Asp (OMe)-fluoromethyl ketone (z-VAD-fmk) blocked DNA fragmentation. Release of Smac/DIABLO from the
mitochondria through the TIP30–P53–Bax cascade was required to remove the inhibitory effect of XIAP (X-linked Inhibitor of Apoptosis) and
allowed apoptosis to proceed. Our results showed for the first time that Bax-dependent release of Smac/DIABLO, cytochrome c and AIF from the
mitochondria mediated the contribution of the mitochondrial pathway to TIP30-mediated apoptosis. Our data suggested that adenovirus-mediated
overexpression of TIP30 was capable of inducing therapeutic programmed cell death in vitro by activating the mitochondrial pathway of apoptosis.
On the basis of these studies, elucidating the mechanism by which TIP30 induces cell death might establish it as an anticancer approach.
© 2007 Elsevier B.V. All rights reserved.Keywords: Hepatocellular carcinoma; TIP30; Bax; Bcl-xL; Cytochrome c; Smac/DIABLO1. Introduction
TIP30 (also known as CC3), 242-amino-acid long, is
evolutionary conserved and expressed ubiquitously in human
tissues and some tumor tissues with serine/threonine kinase
properties. CC3 was first identified as a metastasis suppressor for
small cell lung carcinoma (SCLC) and predisposed cells to
apoptosis in response to death signals. Subsequently, CC3 was
independently identified as a protein named TIP30, which en-
hanced human immunodeficiency virus-1 (HIV-1) Tat-activated
transcription by phosphorylating the heptapeptide repeats of the
C-terminal domain (CTD) of the largest RNA polymerase II
subunit [1,2]. It was a putative metastasis suppressor that pro-
moted apoptosis and inhibited angiogenesis [3,4]. TIP30-⁎ Corresponding author. Tel.: +86 531 88364326; fax: +86 531 88564326.
E-mail address: clubstone@sdu.edu.cn (M. Shi).
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doi:10.1016/j.bbamcr.2007.10.006deficient mice had a high susceptibility of hepatocellular carci-
noma and other tumors. Therefore, some carcinomas harbored
missense mutations in the tip30 gene [5–7]. Furthermore, studies
showed that TIP30 was an important proapoptotic factor that
accounted for significant growth retardation in small cell lung
carcinoma (SCLC), which could be largely mediated by the
ability of TIP30 to promote apoptosis [2,8]. Moreover, ec-
topic expression of TIP30 in SCLC cells induced a number of
apoptosis-related genes, such as Bad and SIVA [9]. Nevertheless,
the molecular mechanism by which the TIP30-mediated
apoptosis had remained largely unknown.
Recently, induction of TIP30 in tumor cells was shown to
correlate with chemosensitivity to 5-FU. These data implicated
exogenous expression of TIP30 sensitized HCC cells to cytotoxic
drugs and to apoptosis induced by tumor necrosis factor-related
ligands in vitro [10]. Later studies showed that TIP30 might
abolish its native tumor-suppressor activity and gain oncogenic
activities partially through up-regulation of N-cadherin, thereby
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recently showed that tip30 gene transferred by adenovirus-
mediated effectively induced apoptosis in HCC cells in a time-
dependent manner. TIP30 predisposed HCC cells to apoptosis
according to the P53 pathway. The tumor-suppressor P53 could
induce growth arrest and apoptosis in response to a number of
cellular stresses. The results showed that when HepG2 cells were
infected with Ad-TIP30, levels of wide P53 were increased in a
time-dependent manner with an asynchronous apoptosis. We
further analyzed p53 mRNA level by real-time PCR. The p53
mRNAwas significantly enhanced after Ad-TIP30 infection. The
Bax gene promoter was highly P53-responsive and its expression
was up-regulated by P53. We further evaluated the role of Bax
in Ad-TIP30-mediated apoptosis. Total Bax levels were elevated
2-fold higher than controls, demonstrating that the influence upon
Bax was caused by asynchronous activation of P53. Consistent
with the elevation of Bax, a decrease of Bcl-xL was found in cells
infected by Ad-TIP30 [10,12]. Although the functions of many
molecules and genetic pathways involved in TIP30-mediated
apoptosis have begun to be established, our understanding of the
details remains fragmented.
Apoptosis is induced in response to a variety of environ-
mental stressors such as heat shock, radiation, various chemo-
therapeutic agents, and oxidative stress [13,14]. The two major
apoptotic pathways involve either mitochondria or death re-
ceptors. In the mitochondria, death signals lead to changes in
mitochondrial membrane permeability and the subsequent release
of proapoptotic factors, including cytochrome c, apoptosis
inducing factor (AIF), second mitochondria-derived activator of
caspase (Smac/DIABLO), and endonuclease G. This leads to the
cytoplasmic assembly of procaspase-9, cytochrome c, and apo-
ptosis protease-activating factor 1 (Apaf-1) into an initiation
complex known as the apoptosome [15–17]. Formation of the
apoptosome leads to the activation of caspase-9 and subsequent
activation of “executioner” caspases such as caspase-3, which is
blocked by the inhibitor-of-apoptosis proteins (IAPs). The IAP
family of proteins regulates apoptosis by preventing the action of
the central execution phase of apoptosis through direct inhibition
of the effector caspase-3 and/or caspase-7. In addition, they pre-
vent initiation of the intrinsic caspase activation cascade by
directly inhibiting both apical and effector caspases [18,19].
Smac/DIABLO functions to promote caspase activation by
inhibiting IAP family proteins, thereby relieving the block on
caspase activation [20,21]. Moreover, AIF and endonuclease G
translocate directly to the nucleus where they induce chromatin
condensation and/or DNA fragmentation [22].
Mitochondria play a pivotal role in regulating apoptosis.
The key regulatory proteins of mitochondria-mediated apopto-
sis are the Bcl-2 family of proteins, which can either pro-
mote cell survival (Bcl-2 and Bcl-xL), or induce cell death
(Bax and Bak). Bcl-2 and Bcl-xL are required for the main-
tenance of mitochondrial integrity by inhibiting the mitochon-
drial release of proapoptotic factors. On the other hand, Bax and
Bak are sufficient to initiate the loss of outer mitochondrial
integrity, resulting in apoptosis [23–25]. Bax is distributed in
many tissues and promotes apoptosis in a wide variety of cell
types. Upon signal stimulation, Bax translocates to mitochon-dria where it facilitates the release of cytochrome c. More
recently, studies have provided direct evidence that Bax is
required for the execution of the intrinsic apoptotic pathway in
response to certain anticancer agents [26,27]. Bcl-xL can be
detected in numerous tumor cell lines, particularly in HCC cells.
In contrast, it exerts an anti-apoptotic effect by blocking Bax
translocation to the mitochondria, preserving mitochondrial
integrity and preventing the subsequent release of apoptogenic
molecules [28,29].
To date, a substantial literature has detailed many specific
biochemical events that occurred upon TIP30 in a few cell types
showing apoptotic characteristics. In most cases, these reports
dealt with a relatively limited portion of a clearly multiple step
process. Accordingly, how these individual events are coupled
to more proximal and distal ones is not fully understood. Our
previous studies supported that P53 played a vital role in TIP30-
mediated proapoptotic activity. In this study, we construct
replication-defective adenoviral vectors containing the tip30
gene or lacZ gene. To further study the TIP30-mediated apo-
ptotic pathway, we analyze the translocation of Bax, release of
Smac/DIABLO and elimination of XIAP to caspases in HCC
cells. In the current study, we demonstrate the status of mito-
chondria and its downstream effectors in TIP30-mediated path-
way. In particular, the data help to detail a sequence of events
that proceeds from the translocation of Bax through the release
of cytochrome c to activation of caspases.
2. Materials and methods
2.1. Antibodies and reagents
Antibodies against cytochrome c were purchased from Oncogene Research
Products, (San Diego, CA); caspase-3, -8, -9, poly (ADP-ribose) polymerase,
Smac/DIABLO, XIAP, and AIF were all purchased from Sigma (St Louis, MO).
All antibodies were diluted 1:2000 or 1:1000, in BSA (diluted in TBST).
Secondary antibodies were diluted 1:000 or 1:2000 with 5% non-fat milk
(diluted in TBST). Z-LEHD-fluoromethyl ketone (z-LEHD-fmk) and benzylox-
ycarbonyl-Val-Ala-Asp (OMe)-fluoromethyl ketone (z-VAD-fmk) were also
purchased from Sigma (St Louis, MO).
2.2. Recombinant adenoviruses and infection protocol
The recombinant adenovirus vectors expressing human TIP30 cDNA were
constructed by standard protocols as described previously [31,32]. The resultant
viruses were named Ad-TIP30. An adenovirus vector carrying LacZ gene was
used for monitoring infection efficiency. All vectors were propagated in 293
cells, purified, and stored at −80 °C, as described previously [31].
2.3. Cell culture conditions and establishment of HepG2 cells stably
expressing Bcl-xL
HCC cells: HepG2 and HepG2 cells transfected with control vector or Bcl-
xL were maintained in six-well plates with 2 ml of Dulbecco's Modified Eagle's
Medium (DMEM) containing 10% fetal bovine serum (FBS) under an
atmosphere of 5% CO2. Medium of transfected cells was supplemented with
1 mg/ml G418 (Life Technologies, Inc., Eggenstein, Germany) every fifth
passage.
HepG2 cells were transfected with a pcDNA3.1 vector (Invitrogen, SanDiego,
CA) containing the coding sequence for Bcl-xL (pcDNA3.1/Bcl-xL) or with a
control, neomycin-resistant expression vector pcDNA3.1 by Lipofectin reagent
(Invitrogen) according to the manufacturer's instructions. Transgene expression
was assessed by Western blot.
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Several methods were used to confirm apoptotic cell death. In situ TUNEL
assay identified internucleosomal DNA strand breaks characteristic of apo-
ptosis. A TdT-FragEL DNA fragmentation detection kit (Oncogene Research
Products, San Diego, CA) was used to detect apoptosis, according to in-
structions provided by the manufacturer. Cells were harvested by trypsinization
and washed once in TBS at indicated times post infection with Ad-TIP30 with
mock as control. Then cells were fixed by 4% formaldehyde/PBS at a cell
density of 1×106. Proteinase K was added (20 μg/ml), incubating at room
temperature for no more than 5 min. Cells were in turn equilibrated by 1×TdT
equilibration buffer for 10–30 min. At this end, cells were incubated in TdT
reaction mixture at 37 °C, 5% CO2 for 1–1.5 h. Afterward, cells were analyzed
on a flow cytometry equipped with a 488 nm argon ion laser source (Trevigen,
Inc. Gaithersburg, MD).
2.5. Measurement of mitochondrial transmembrane potential (Δψm)
The detection of mitochondrial membrane potential (Δψm) was determined
according to the instruction of Trevigen (Trevigen, Inc. MD.). Cells were stained
with the fluorochrome 5,5′, 6-6′tetrachloro-1, 1′, 3, 3′-tetraethylbenzimidazol-
carbo-cyanine iodide (JC-1 (1.25 μg/ml)). HepG2 cells incubated in six-well
plates were washed with PBS (phosphate-buffered saline), then 1 ml reaction
buffer/well mixed by 1 μl DePsipher™ (Trevigen) was incubated at 37 °C, 5%
CO2 for 15–20 min. Finally, cells were observed immediately under confocal
laser scanning microscopy using a fluorescent long-pass filter. In healthy cells,
the mitochondria appeared red following aggregation of the DePsipher within
the mitochondria. The red aggregates had a maximal emission at 590 nm (FL-2).
In dying cells or cells with disrupted potential, the dye remained in its
monomeric form in the cytoplasm and would appear green with a maximal
emission at 530 nm (FL-1). Alternately, disrupted membrane potential was also
assayed by flow cytometry (Trevigen).
2.6. Isolation of cytosol and mitochondrial fractions
Cells were washed twice with PBS, and harvested by centrifugation (500 ×g
for 5 min). Cell pellets were resuspended in 1000 μl of cytosol extraction buffer
(Biovision, Mountain View, CA). Cell homogenates were prepared by disrupting
cells in a Dounce glass homogenizer (30–50 strokes) on ice. Unlysed cells and
nuclei were subjected at 700 ×g for 10 min at 4 °C. The supernatant, which
contained mitochondria, was collected and subjected to further centrifugation at
10,000 ×g for 30 min. The pellet and the supernatant represented mitochondrial
and cytosolic fractions, respectively.
2.7. Western blot analysis and immunoprecipitation
Briefly, the protein content of cell extracts was determined by the Bradford
assay [30] (Bio-Rad, Sydney, New SouthWales, Australia). Equal amount of
protein loading was further controlled by Coomassie Blue staining of gels. A
total of 20–50 μg of protein was electrophoresed on 10–15% SDS-PAGE gels
and transferred to polyvinylidene difluoride membranes (Immobilon-P;
Millipore, Eschborn, Germany). Membranes were blocked with 5% fat-free
milk powder in TBST containing 0.05% Tween 20 (for 1 h) and incubated with
specific antibodies against caspase-3, caspase-8, caspase-9, XIAP, poly (ADP-
ribose) polymerase, cytochrome c, AIF, and Smac/DIABLO overnight at 4 °C.
The probed blots were washed and incubated with a horseradish peroxidase-
coupled anti-rabbit or anti-mouse IgG, and then visualized by ECL Advance
Western Blotting Detection Kit (GE Healthcare, UK).
For immunoprecipitation, cells were lysed as described previously
(Biovision, Mountain View, CA). Lysates were cleared by centrifugation at
14,000 ×g for 10 min at 4 °C and protein concentration was determined. Cytosol
cell lysates were incubated with anti-Smac antibody or anti-caspase-3 antibody
(2.5 μl) and protein A Sepharose (GE Healthcare, UK) overnight at 4 °C. The
beads were washed three times with 500 μl of lysis buffer and resuspended in
25 μl of a 3× sample buffer containing 1.5% β-mercaptoethanol. After addition
of 25 μl of 1× sample buffer, beads were boiled for 5 min at 95 °C and then
pelleted by short spin. 50 μl of the supernatant were used for SDS-PAGE.2.8. RNA interference
The sequences against human Bax were initially synthesized according to
human Bax cDNA sequence using the Silencer™ kit (Ambion, Austin, TX). The
Bax DNA target sequence for siRNA design was 5′-AACTGATCAGAACCAT-
CATGG-3′. Nonspecific control siRNA (target 5′GCATTGTATGCGATCGCA-
GAC’) was acquired. The transfection of siRNAoligonucleotides was performed
with Lipofectamine 2000 (Invitrogen) according to the manufacturer's
recommendations. Forty-eight hours after transfection, the cells were treated
with Ad-TIP30. At the end of treatment, the cells were harvested for experiments.3. Results
3.1. TIP30-induced inner mitochondrial membrane
permeabilization and release of Smac/DIABLO, cytochrome c
and AIF
Hallmarks of the mitochondrial apoptosis pathway (intrinsic
pathway) are the release of cytochrome c from the mitochon-
drial intermembrane space into the cytosol and the dissipation of
the electrochemical gradient on the inner mitochondrial mem-
brane (inner mitochondrial membrane permeabilization) [33].
Fig. 1A and B showed that TIP30 (20 MOI) induced outer
mitochondrial membrane permeabilization in HepG2 cells as
measured by flow cytometry and observed by confocal laser
scanning microscopy using the fluorochrome JC-1. The first
significant dissipation of Δψm was evident 2 h after stimu-
lation. Moreover, TIP30 (20 MOI, 0–24 h) triggered the release
of cytochrome c into the cytosol (Fig. 1C). Besides cytochrome
c, AIF and Smac/DIABLO were presented within the mito-
chondria and released after apoptotic stimuli (Fig. 1D and E).
TIP30 triggered an early (2 h) release of Smac/DIABLO that
was not abrogated by the pan-caspase inhibitor z-VAD-fmk.
This indicated that TIP30-induced Smac/DIABLO release was
an early event that occurred before and independent of caspase
activation (Fig. 1E).
3.2. TIP30-induced apoptosis was dependent on the activation
of caspases
To elucidate whether caspase activation was required for
TIP30-induced apoptosis, cells were pre-incubated with the
broad-spectrum caspase inhibitor benzyloxycarbonyl-Val-Ala-
Asp (OMe)-fluoromethyl ketone (z-VAD-fmk). Caspase inhibi-
tion led to a complete inhibition of TIP30-induced DNA frag-
mentation (Fig. 2A), proving the evidence of caspases in this
TIP30-mediated apoptosis. To explore whether TIP30-triggered
apoptosis followed the extrinsic pathway including activation of
the initiator caspase-8 or the intrinsic pathway under involve-
ment of mitochondria and the initiator caspase-9, we examined
the activation of these caspases by Western blot assay. The
caspase-8 cleavage did not appear until 24 h after stimulation
(Fig. 2B). In contrast, Fig. 2C illustrated the time-dependent
activation of caspase-9 by TIP30 (20 MOI). The processing of
procaspase-9 to the active forms (p37) occurred after only 4 h.
To test whether caspase-3, an important effector caspase, was
activated downstream of caspase-9, the processing of caspase-3
and poly (ADP-ribose) polymerase cleavage in response to
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treatment caused proteolytic cleavage of both caspase-3
and PARP in a time-dependent manner. On the other hand,
inhibition of caspase-9 by the caspase-9 inhibitor z-LEHD-
fluoromethyl ketone (z-LEHD-fmk) (50 μM) led to an
inhibition of caspase-3 activity induced by Ad-TIP30 (Fig. 2C).3.3. Membrane translocation of Bax was essential for
TIP30-mediated apoptosis and loss of Bax inhibited
mitochondrial release of Smac/DIABLO and cytochrome c
In normal cells, the Bax protein exists as an inactive form in
the cytosol, but it can be induced to change conformation and
Fig. 2. TIP30-induced apoptosis is dependent on the activation of caspases. A, Inhibition of Ad-TIP30-induced apoptosis by the caspase inhibitor z-VAD-fmk. Cells
were infected with Ad-TIP30 (50MOI, 0–24 h), or pretreated with z-VAD-fmk (25 μM, 1 h) and then stimulated by Ad-TIP30. Apoptotic cells were quantified by flow
cytometry. B and C, Representative Western blots showed time-dependent (0–24 h) cleavage as follows: B, Procaspase-8 isoforms were not cleaved to the p42 and p44
cleavage products in cells treated with Ad-TIP30 and Ad-vector. Positive control: HCC cells were treated with 100 ng/ml of TRAIL for 24 h. C, Procaspase-9 was
cleaved to the active cleaved forms p37. Procaspase-3 was cleaved to p20/17 and 116-kDa PARP was cleaved to its p89 cleavage product after treatment with Ad-
TIP30 (20 MOI). Moreover, cells were treated by a caspase-9 inhibitor (Casp 9IH) in addition to Ad-TIP30 (20 MOI) for 24 h. Whole cell extracts were analyzed by
Western blots. Cells were lysed and proteins were separated by SDS-PAGE as described in “Materials and methods”. Data represented means and S.E. from three
independent experiments. Pb0.05(⁎) and Pb0.01(⁎⁎) indicated a statistically significant difference with various treatment.
267M. Shi et al. / Biochimica et Biophysica Acta 1783 (2008) 263–274translocate to the mitochondria in response to certain apoptotic
stimuli [34]. We took advantage of a Bax-interfered cell line
(Bax siRNA cells) derived from HepG2/Bax+/+ cells. ReductionFig. 1. Ad-TIP30 induces innermitochondrialmembrane permeabilization and themitocho
a time-dependent dissipation ofΔψm.HepG2 cells were incubated with Ad-TIP30 (20MO
(0.25 μg/ml). Cells showing predominantly green fluorescence were quantified by FACS a
Cellswere either left untreated (no virus) or infectedwithAd-control orAd-TIP30 (20MOI
are shown. Control cells and cells treated by Ad-control or Ad-TIP30 were viewed by DIC
and Ad-TIP30-F). (magnification ×200) C, D and E, Ad-TIP30 led to release of cytochrom
TIP30 (20MOI) for the indicated times. Cytoplasmic andmitochondrial protein were prepa
cells were pretreatedwith z-VAD-fmk (25μM, 1 h) where indicated and subsequently stim
were prepared and analyzed as described in C and D. RepresentativeWestern blots are show
and Pb0.01(⁎⁎) indicated a statistically significant difference with Ad-TIP30 and the conof Bax expression in HepG2/Baxsi cells was first confirmed by
Western blot assay (Fig. 3A). Forty-eight hours after transfec-
tion, HepG2 cells were treated with Ad-TIP30. Most HepG2/ndrial release of Smac/DIABLO, cytochromec andAIF.A,Left lane:Ad-TIP30 led to
I) for the indicated time periods and subsequently loadedwith the fluorochrome JC-1
nalysis. Right lane: the expression of TIP30 in HepG2 cells treated with Ad-TIP30. B,
) for 24 h and prepared for confocal laser scanningmicroscopy.Representative pictures
(control-P, Ad-control-P and Ad-TIP30-P) and fluorescence (control-F, Ad-control-F
e c (C), AIF (D) or Smac/DIABLO (E) into the cytosol. Cells were treated with Ad-
red as described in “Materials andmethods” and detected byWestern blot analysis. E,
ulated with Ad-TIP30 (20MOI) for 2 and 4 h. Cytoplasmic andmitochondrial protein
n. Data representedmeans and S.E. from three independent experiments.Pb0.05(⁎)
trol.
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Ad-TIP30, whereas little apoptosis was observed in HepG2/
Baxsi cells (Fig. 3A). Treatment of HepG2/Baxsi cells with Ad-
TIP30 for 48 h did not result in significant cell death (dataFig. 3. Requirement of Bax translocation in TIP30-induced apoptosis. A, Left lane: S
were transfected with Bax siRNA (Baxsi) or control siRNA (controlsi). After 48 h
apoptotic cells were quantified by flow cytometry. Right lane: expression of Bax and B
B, Time-dependent dissipation of Δψm was quantified by FACS analysis as previou
cells were treated by Ad-TIP30 (20 MOI), and Bax protein was detected on a W
was performed on cells after Ad-TIP30 treatment for 4 h in HepG2/Baxsi and Hep
Western blot for Smac/DIABLO and cytochrome c. E, Western blotting was performe
and S.E. from three independent experiments. Pb0.05(⁎) and Pb0.01(⁎⁎) indicatednot shown), suggesting that Bax was required for Ad-TIP30-
induced apoptosis in HepG2 cells. Moreover, the significant
dissipation of Δψm was abrogated in HepG2/Baxsi cells
(Fig. 3B).uppression of Ad-TIP30-induced apoptosis in HepG2/Baxsi cells. HepG2 cells
, cells were treated with Ad-TIP30 (50 MOI) for indicated time periods, and
ak in HepG2/Baxsi and HepG2/controlsi cells was detected byWestern analysis.
s description. C, Change of Bax distribution after Ad-TIP30 treatment. HepG2
estern blot from cytosol and mitochondrial extracts. D, Subcellular fraction
G2/controlsi cells. Pellets and supernatants (cytosol fraction) were analyzed by
d to analyze for the cleavage of procaspase-3 and PARP. Data represented means
a statistically significant difference with various treatment.
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TIP30-mediated apoptosis, HepG2/Bax+/+ cells were treated
with Ad-TIP30, and Bax localization was examined by sub-
cellular fractionization followed by Western blot. The Bax
protein was located in the cytosol before Ad-TIP30 treatment
and was redistributed to mitochondria after Ad-TIP30 treatment
(Fig. 3C), suggesting that Ad-TIP30 induced Bax translocation.
These results suggest that Bax translocation from the cytosol to
mitochondria was required for Ad-TIP30-induced apoptosis.
One of the events mediated by Bax is the release of
cytochrome c from mitochondria, followed by procaspase-9
activation. The Smac/DIABLO protein is also redistributed fromFig. 4. Bcl-xL delays mitochondrial Smac/DIABLO release and onset of apoptosis a
overexpressing Bcl-xL (HepG2/Bcl-xL) were treated with Ad-TIP30 (50 MOI). Apop
the level of Bcl-xL in HepG2 cells, cells transfected with a pcDNA3.1 vector or with
FACS analysis as previous description. C, Down-regulation of Bcl-xL was detected in
such as cytochrome c and Smac/DIABLO, were detected usingWestern blot analysis.
and Pb0.01(⁎⁎) indicated a statistically significant difference with various treatmentmitochondria to cytosol during mitochondria-initiated apopto-
sis, concurrent with cytochrome c relocalization [35]. There-
fore, we investigated whether reduction of the Bax could block
Smac/DIABLO and cytochrome c release and procaspase-9 or
procaspase-3 activation in the TIP30-signaling pathway. As
shown in Fig. 3D, Bax down-regulation almost completely
inhibited the apoptotic stimuli-induced cytochrome c and Smac
release. Moreover, the cleaved caspase-3 and PARP appeared in
HepG2/controlsi cells 4 h after Ad-TIP30 treatment. In contrast,
procaspase-3 cleavage was absent in HepG2/Baxsi cells
(Fig. 3E). Consistent with the finding that cytochrome c release
was absent in these cells, the data showed that procaspase-3 ands well as dissipation of Δψm. A, Left lane: control cells (HepG2/neo) and cells
totic cells were quantified by flow cytometry for the indicated times. Right lane:
pcDNA3.1/Bcl-xL. B, Time-dependent dissipation of Δψm was quantified by
cells treated by TIP30 (20 MOI) for the indicated times. D, Cytoplastic proteins,
Data represented means and S.E. from three independent experiments. Pb0.05(⁎)
.
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reduction of Bax. These results showed that the mitochondrial
pathway was activated by Ad-TIP30 treatment in a Bax-de-
pendent manner.
3.4. Bcl-xL down-regulation was required for TIP30-induced
apoptosis
Bcl-xL appears to inhibit cell death by blocking the for-
mation of these cytochrome c-releasing pores. Previous studies
had shown that Bcl-xL might be down-regulated during
apoptosis induced by chemotherapy reagents [36,37]. After
treatment with Ad-TIP30, the level of Bcl-xL was markedly
decreased in HepG2/neo cells (Fig. 4C). In the apoptotic assay,
compared with the control HepG2/neo cells, the HepG2/Bcl-xL
cell expressed approximately 2–3-fold higher levels of Bcl-xL
(Fig. 4A). Ad-TIP30 treatment induced apoptosis in 60% of
control HepG2/neo cells, but little cell death was observed after
exposing HepG2/Bcl-xL cells to Ad-TIP30 treatment for 24 h
(Fig. 4A). Similarly, dissipation of Δψm was also affected by
overexpression of Bcl-xL (Fig. 4B). Fig. 4D showed that release
of cytochrome c and Smac/DIABLO was significantly delayed
in HepG2/Bcl-xL cells compared with HepG2/neo cells. TheseFig. 5. Interaction between XIAP and Smac/DIABLO in Ad-TIP30-induced
apoptosis. A and B, Cells treated with Ad-TIP30 (20MOI) for 4 h and whole cell
extracts were examined for Smac/DIABLO and XIAP protein expression on
Western blots. Cytosol extracts were immunoprecipitated with anti-XIAP and
Smac/DIABLOantibodies, and blotted for Smac/DIABLOandXIAP, respectively.
C, Cells treated with Ad-TIP30 for 4 h and whole cell extracts were examined for
Smac/DIABLO and XIAP protein expression with Western blots.results confirmed that Ad-TIP30-induced apoptosis was
initiated by mitochondrial release of apoptogenic molecules
and regulated principally by Bax and Bcl-xL in HCC cells.
3.5. Interaction between XIAP and Smac/DIABLO in
Ad-TIP30-induced apoptosis
One of the factors released from mitochondria during
apoptosis is the Smac/DIABLO protein, which binds and neu-
tralizes the inhibitory activity of IAPs, especially XIAP, and
physically facilitate caspases activation in cancer cells [38,39].
Immunoblotting revealed that Smac/DIABLO and XIAP were
readily detectable in whole cell extracts (Fig. 5C). Association
between Smac/DIABLO and XIAP was analyzed by coimmu-
noprecipitation of cytosol extracts obtained from HCC cells
before and after Ad-TIP30 treatment. More importantly, immu-
noprecipitation of XIAP coimmunoprecipitated cytosolic Smac/
DIABLO in HepG2/controlsi cells treated with Ad-TIP30
(Fig. 5). These results supported the hypothesis that Bax-
dependent release of Smac/DIABLO from mitochondria
enabled Smac/DIABLO to interact with XIAP thereby disrupt-
ing the XIAP–caspase interaction, thus allowing caspase auto-
cleavage and functional activation.
4. Discussion
To investigate the signaling pathway of TIP30-mediated
apoptosis, we took advantage of a recombinant adenovirus-
mediated delivery system. Adenovirus was used to deliver
genes into mammalian cells, particularly where there was a
requirement for high-level expression of transgene products in
cultured cells. Full length TIP30 was cloned into a replication
deficient recombinant adenovirus and the expression of TIP30
was verified by Western blot analysis. A higher expression level
of TIP30 was observed in cells transduced with Ad-TIP30 as
compared to negative control (Fig. 1A).
We had shown that TIP30 underwent P53-dependent cell
death cascade [11,12], consistent with the idea that TIP30-
induced apoptosis was mediated by a common mitochondrial
pathway. Most importantly, we had shown that mitochondrial
cell death events were activated by TIP30 stimulation in a Bax-
dependent manner and that apoptosis was ignored in HepG2/
Baxsi cells. This is the first report showing that TIP30 triggered
an intrinsic apoptosis in HCC cells that used mitochondria as a
signaling integrator and Smac/DIABLO as a main TIP30-
signaling molecule. Based on the results from previous reports
by others and our present studies, we proposed a sequence of
signal transduction events involved in TIP30 (Fig. 6).
The cellular signal generated by TIP30 used mitochondria to
culminate in the common execution pathway triggered by cyto-
chrome c. The cytosolic cytochrome c formed a complex with
Apaf-1 and procaspase-9 in the presence of ATP, which led to the
activation of caspase-9. Activated caspase-9 further activated
other caspases such as caspase-3, and then resulted in apoptosis.
We first studied the mitochondrial membrane potential (Δψm)
uponAd-TIP30 exposure. Thus, it appeared that themitochondria
were an important target for TIP30-induced apoptosis (Fig. 1).
Fig. 6. Proposed model of Ad-TIP30-induced Bax translocation in regulating apoptosis. Stimulation of P53 resulted in up-regulation of Bax. Then Bax translocated
from the cytoplasm to the outer mitochondrial membrane, where it stimulated release of both cytochrome c, AIF and Smac/DIABLO. Because Smac efficiently
removed XIAP from active caspases, and in turn promoted their activity. Procaspase-9 subsequently underwent transcatalytic processing, resulting in active caspase-9
that cleaved its substrates, procaspase-3. Initial processing of procaspase-3 produced an active caspase-3 intermediate, whereas Bcl-xL could modulate cell death by
inhibiting release of cytochrome c and Smac.
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dria-initiated caspase activation pathway [40]. The present study
was designed to gain insights into the role of these Bcl-2 family
members in TIP30-mediated apoptosis. Whitman [8] had
previously reported that TIP30/CC3 induced apoptosis in a
Bcl-2-inhibitable fashion involving perturbation of mitochon-
dria in SCLC cells. Previous studies showed that induction of
apoptosis by diverse antitumor drugs in different cellular
systems was associated with the induction of Bax translocation.
In normal cells, the Bax existed in an inactive form mainly in the
cytosol but could be induced to change conformation and
translocate into the mitochondria in response to certain apoptoticstimuli. The conformationally changed Bax protein oligomer-
ized on the outer mitochondrial membrane and induced the
release of apoptogenic molecules into the cytoplasm [41,42]. To
determine whether Bax translocation was involved in TIP30-
induced apoptosis, we performed subcellular fractionation and
Western blot analysis on HepG2 cells infected by Ad-TIP30 at
several time intervals. This conclusion was based on the
following observations: (a) Ad-TIP30 treatment causes a time-
dependent translocation of Bax in wild-type cells (Fig. 3C),
(b) the HepG2/Baxsi cells prevented TIP30-induced HCC cell
death when compared with HepG2/controlsi cells (Fig. 3A), and
(c) data indicated that membrane translocation of Bax led to
272 M. Shi et al. / Biochimica et Biophysica Acta 1783 (2008) 263–274activation of caspase-3 and PARP (Fig. 3E). These data
suggested that translocation of Bax was necessary and sufficient
for complete processing mitochondrial cascade in the TIP30-
mediated cell death pathway.
It was well established in the literature that Bcl-xL was highly
expressed inmany cell types, especially inHCC cells. It possesses
properties of attenuating cell death at the mitochondrial level,
preventing the release of cytochrome c and the loss ofΔψm [43].
Indeed, resistance to chemotherapywas related to increased levels
of the mitochondria-protecting proteins Bcl-2 and Bcl-xL.
Previous reports demonstrated that ectopic expression of Bcl-xL
in cancer cells conferred resistance to apoptosis against a variety
of death-inducing agents [44,45]. Similarly, our data indicated
that infected by Ad-TIP30, Bcl-xL protein level decreased in
HepG2 cells, implying that overexpression of TIP30might trigger
apoptosis at least by down-regulating Bcl-xL in HCC cells
(Fig. 4C). Changes in the Δψm were retarded by overexpression
of Bcl-xL, which resulted in a marked delay in the kinetics of
apoptosis (Fig. 4A and B). It would be consistent with induction
of changes in Bax by Ad-TIP30 (Fig. 3). In conclusion, over-
expression of Bcl-xL was associated with suppression of cyto-
chrome c/Smac/DIABLO release (Fig. 4D).
One of the key regulatory steps for apoptosis is the activation
of caspase. Active caspase then cleaved many important intra-
cellular substrates, leading to the characteristic morphological
changes associated with apoptotic cells [46]. To determine
whether mitochondiral/caspase-9 pathway was activated in Ad-
TIP30-induced apoptosis in HepG2 cells, we analyzed the
cleavage product of caspase-3, -9 and PARP by western blotting.
The result showed that in HepG2 cells, both caspases were
activated during apoptosis as judged by appearance of cleavage
products from procaspase (Fig. 2C). Previous studies in vitro
had suggested that caspase-9 could directly process procaspase-
3 into its active form by two distinct cleavage events [47]. As
expected, we had shown that inhibition of caspase-9 blocked
caspase-3 processing and activation in HepG2 cells (Fig. 2C).
Consistent with earlier study documented the specific role of
caspase-3 as an amplifier of mitochondrial cytochrome c release
and of morphological changes of nuclei and DNA fragmentation
during adenovirus-induced apoptosis in hepatocellular carci-
noma cells [48].
Smac/DIABLO was identified as a mitochondrial factor
involved in apoptosis by removing XIAP inhibition on caspases.
During stress-induced apoptosis, Smac/DIABLO was released
along with cytochrome c from mitochondria into the cytosol.
Although released cytochrome c contributed to the formation of
the apoptosome and thereby to the initiation of the caspase-3-
dependent caspase cascade. Smac/DIABLO promoted caspase
activity by binding to the XIAP in a manner that displaced
caspases from their inhibitor XIAP [49–52]. In this setting,
Smac/DIABLO release was sufficient to promote full caspase
activation. The function of Smac/DIABLO in the cytosol ap-
peared to dissociate caspase–XIAP interaction, as shown by
coimmunoprecipitation of XIAP and Smac/DIABLO (Fig. 5).
Previous studies have demonstrated that chemical substance
such as O-Trensox, Doxorubicin, MG132 could facilitate HCC
cells to undergo apoptosis by P53 elevation, increase of pro-apoptotic members and down-regulation of anti-apoptotic
members of Bcl-2 family, or moreover by reduction in mito-
chondrial transmembrane potential with the consequence of
activation of caspase-3 and degradation of PARP [53,54]. We
had shown that P53-deficient-Hep3B and P53-mutational-PLC/
RPF/5 cells displayed a relatively low apoptotic rate with Ad-
TIP30 infection. Thus, P53 might be a major factor regulated by
TIP30 and enhanced the process of apoptosis. Nevertheless, the
apoptotic pathway of the two kinds of cells required further
experiments. It was still worth that we established a common
mechanism by which diverse factor predisposed HCC cells to
apoptosis. Based on our results and the results from others, we
proposed the following model (Fig. 6): upon activation of P53
by TIP30, P53 in turn activated the downstream factor, mostly
like Bax. Thereby triggered the translocation of Bax to mito-
chondria where it promoted the release of cytochrome c, AIF and
Smac/DIABLO. Smac efficiently removed XIAP from active
caspases and procaspase-9 subsequently underwent transcatalytic
processing, resulting in active caspase-9. Then it cleaved its
substrates, such as procaspase-3, leading to apoptosis.
Given that TIP30 is a promising potential anticancer agent,
understanding the contribution of TIP30 to apoptosis is of sig-
nificance for the development of its therapy for human hepato-
blastoma. Impairment in mitochondrial activation is frequently
associated with cancer development, such as mutations in
Bax and loss of function of Apaf-1. Therefore, Bax and Smac/
DIABLO represent potential therapeutic targets to bypass the
involvement of the mitochondrial pathway and improved TIP30
cancer therapy.
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